SAVA
Price:
$1.32
Market Cap:
$42.01M
Cassava Sciences, Inc. is a biopharmaceutical enterprise in the clinical development phase, specializing in the creation of treatments for neurodegenerative disorders. The company's primary experimental drug, simufilam, a small-molecule compound, has successfully concluded its Phase 2b clinical trials. In parallel, they are advancing SavaDx, an investigational blood-based biomarker test designed to aid in the detection of Alzheimer's disease. Established in 1998 and headquartered in Austin, Texas, the company underwent a name change in March 2019, previously operating as Pain Therapeutics, Inc.
Industry
Biotechnology
IPO Date
2000-07-14
Stock Exchange
NASDAQ
Ticker
SAVA
According to Cassava Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -99.85%. This represents a change of 318.06% compared to the average of -23.88% of the last 4 quarters.
The mean historical ROE of Cassava Sciences, Inc. over the last ten years is -24.45%. The current -99.85% ROE has changed 308.30% with respect to the historical average. Over the past ten years (40 quarters), SAVA's ROE was at its highest in in the September 2025 quarter at -13.25%. The ROE was at its lowest in in the June 2025 quarter at -50.27%.
Average
-24.45%
Median
0%
Minimum
-122.27%
Maximum
0%
Discovering the peaks and valleys of Cassava Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 0%
Minimum Annual Increase = 0%
Minimum Annual ROE = -122.27%
| Year | ROE | Change |
|---|---|---|
| 2025 | -122.27% | -Infinity% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
The current ROE of Cassava Sciences, Inc. (SAVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-40.76%
5-year avg
-24.45%
10-year avg
-24.45%
Cassava Sciences, Inc.’s ROE is greater than Alector, Inc. (-295.17%), greater than PepGen Inc. (-59.89%), greater than Cybin Inc. (-72.37%), greater than Molecular Partners AG (-66.19%), greater than Nkarta, Inc. (-30.90%), greater than Cardiff Oncology, Inc. (-95.50%), greater than Fate Therapeutics, Inc. (-58.89%), greater than Milestone Pharmaceuticals Inc. (-339.38%), greater than Rani Therapeutics Holdings, Inc. (-245.45%), greater than Elicio Therapeutics, Inc. (-2748.16%),
| Company | ROE | Market cap |
|---|---|---|
| -295.17% | $168.76M | |
| -59.89% | $118.28M | |
| -72.37% | $413.02M | |
| -66.19% | $147.42M | |
| -30.90% | $152.39M | |
| -95.50% | $53.16M | |
| -58.89% | $275.08M | |
| -339.38% | $89.32M | |
| -245.45% | $55.12M | |
| -2748.16% | $55.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cassava Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cassava Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cassava Sciences, Inc.'s ROE?
How is the ROE calculated for Cassava Sciences, Inc. (SAVA)?
What is the highest ROE for Cassava Sciences, Inc. (SAVA)?
What is the 3-year average ROE for Cassava Sciences, Inc. (SAVA)?
What is the 5-year average ROE for Cassava Sciences, Inc. (SAVA)?
How does the current ROE for Cassava Sciences, Inc. (SAVA) compare to its historical average?